Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans-Reference-Cited by-同舟云学术

Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans

Published:2002-10 Issue:15 Volume:16 Page:2019-2025
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Stiegler Gabriela,Armbruster Christine,Vcelar Brigitta,Stoiber Heribert,Kunert Renate,Michael Nelson L,Jagodzinski Linda L,Ammann Christoph,Jäger Walter,Jacobson Jeffrey,Vetter Norbert,Katinger Hermann

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference22 articles.

1. Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 in Primary Infection and Long‐Term‐Nonprogressive Infection

2. Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection

3. A Longitudinal Study of Neutralizing Antibodies and Disease Progression in HIV‐1–Infected Subjects

4. Summary of the Workshop on Passive Immunotherapy in the Prevention and Treatment of HIV Infection

5. Virological and Immunological Data of AIDS Patients Treated by Passive Immunotherapy (Transfusions of Plasma Rich in HIV-1 Antibodies)

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention;Viruses;2024-06-04

2. HIV infection dynamics with broadly neutralizing antibodies and CTL immune response;Discrete and Continuous Dynamical Systems - S;2024

3. Neutralizing the threat: harnessing broadly neutralizing antibodies against HIV-1 for treatment and prevention;MICROB CELL;2024

4. Broadly neutralizing antibodies targeting HIV: Progress and challenges;Clinical Immunology;2023-12

5. Preventive HIV Vaccines-Leveraging on Lessons from the Past to Pave the Way Forward;Vaccines;2021-09-08